Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

Hematopoietic Progenitor Kinase-1 (HPK-1) Inhibition Improves the In Vitro Efficacy of Bispecific Antibodies in CLL

1903 - Hematopoietic Progenitor Kinase-1 (HPK-1) Inhibition Improves the In Vitro Efficacy of
Bispecific Antibodies in CLL